Posted inMedical Technology
NeuroVision acquires fellow dx player Durin Life Sciences
NeuroVision, which is working toward regulatory approval for its early Alzheimer’s detection technology, has acquired fellow diagnostics maker Durin Life…
Posted inMedical Technology
Humacyte cuts spending, staff as it seeks to boost sluggish sales for its off-the-shelf artery implant
Humacyte was riding high in December 2024 when it secured an FDA green light for a groundbreaking implant. Now, as…
Posted inMedical Technology
Medtronic to shutter Santa Rosa plant as it restructures cardiovascular unit
Medtronic will shutter its Santa Rosa facility that produces coronary stents and other heart-related products over the next two years…
Posted inMedical Technology
AstraZeneca pens agentic AI licensing deal with Owkin
AstraZeneca is the latest Big Pharma company looking to tap into agentic artificial intelligence (AI), inking a three-year licensing deal…
Posted inMedical Technology
Charles River debuts AI diagnostic tool to cut down pathology timelines
Charles River is rolling out an artificial intelligence-backed digital pathology platform with a goal of trimming at least one week…
Posted inMedical Technology
Roche nabs European approval for second Eli Lilly-partnered Alzheimer’s test
Roche has grabbed a European CE mark for its second Alzheimer’s test that can both confirm the disease and help…
Posted inMedical Technology
Blood-based approach could detect early heart, kidney disease, study finds
Scientists know that damage to microscopic blood vessels can provide an early warning sign of heart and kidney disease. But…
Posted inMedical Technology
New Hepta blood test could predict GLP-1 response
While GLP-1s like Ozempic and Wegovy are being widely prescribed for weight loss, doctors currently do not have a way…
Posted inMedical Technology
Roche shells out up to $1B for PathAI in move to boost artificial intelligence-powered diagnostics
Roche is set to pay out $750 million upfront to acquire digital pathology specialist Path AI in a move by…
Posted inMedical Technology
Insulet boosts guidance in Q1 update as it grapples with recall saga
Insulet is upping its guidance after a strong first quarter, though ongoing recalls continue to cast a shadow for investors. …